Blog: 3 December 2019
Welcome to one of the widely popular 91ÖÆÆ¬³§ blogs among industry professionals, decision-makers, marketers, journalists, and students.
- 03 Dec
Promising Therapies for B-cell Non-Hodgkin’s Lymphoma (NHL)
Unmet needs remain in B-cell NHL, which will provide opportunities for developers, including the need for predictive and prognostic biomarkers, better therapies for relapsed or refractory DLBCL, further options in FL for specific patient subsets, and therapies for MCL patients refractory to and...





